Aktienanalyse zu Waters Corp (WAT)WATWaters Corp

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Waters Corp (WAT) is a good buy right now, as it is currently priced at $433.77, with a forward P/E ratio of 24.75, suggesting reasonable valuation compared to its growth potential. The stock has shown a strong year-to-date change of +13.56% and a one-year change of +28.97%, indicating solid performance. However, there is a risk with insider selling increasing by 125.80% over the last quarter, which could signal caution among insiders.

15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.